ScholarIQanswers from OpenAlex

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events

PaperCitations, authors & open-access status

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events have?

ScholarIQcitation count

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events has 537 citations in the OpenAlex counts ScholarIQ stores.

When was Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events published?

ScholarIQyear

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events has 1994 year in the ScholarIQ index.

What is the open-access status of Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events?

ScholarIQoa status

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events has closed oa status in the ScholarIQ index.

What is the DOI of Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events?

ScholarIQdoi

The DOI for Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events is on the source record.

What is the PMID of Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events?

ScholarIQpmid

The PMID for Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events is on the source record.

What is the OpenAlex record for Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events?

ScholarIQopenalex

The OpenAlex for Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial